<?xml version="1.0" encoding="UTF-8"?>
<p>In order to target RdRp in the genus 
 <italic>Betacoronavirus</italic>, some therapeutic options including ribavirin, favipiravir, penciclovir, galidesivir, remdesivir, 6ʹ-fluorinated aristeromycin analogs and acyclovir fleximer analogs are available.
 <xref rid="cit0004" ref-type="bibr">4</xref> In clinical trials associated with MERS-CoV and Ebola virus infections, remdesivir (GS-5734) has demonstrated to be beneficial. Moreover, using in vitro and in animal models infected by SARS and MERS coronaviruses, remdesivir has shown to be functional.
 <xref rid="cit0005" ref-type="bibr">5</xref>–
 <xref rid="cit0011" ref-type="bibr">11</xref> Therefore, the drug may be theoretically effective against SARS-CoV-2.
</p>
